Cargando…

Galectins and Ovarian Cancer

Ovarian cancer is known for its aggressive pathological features, including the capacity to undergo epithelial to mesenchymal transition, promoting angiogenesis, metastatic potential, chemoresistance, inhibiting apoptosis, immunosuppression and promoting stem-like features. Galectins, a family of gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimada, Chisa, Xu, Rui, Al-Alem, Linah, Stasenko, Marina, Spriggs, David R., Rueda, Bo R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352943/ https://www.ncbi.nlm.nih.gov/pubmed/32486344 http://dx.doi.org/10.3390/cancers12061421

Ejemplares similares

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
por: Stasenko, Marina, et al.
Publicado: (2021)

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
por: Al-Alem, Linah F., et al.
Publicado: (2019)

Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
por: Bouberhan, Sara, et al.
Publicado: (2020)

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma
por: Eavarone, David A., et al.
Publicado: (2018)

Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner
por: Al-Alem, Linah, et al.
Publicado: (2011)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018)

The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
por: Bellio, Chiara, et al.
Publicado: (2019)

Expression and functions of galectin-7 in ovarian cancer
por: Labrie, Marilyne, et al.
Publicado: (2014)

Galectin-1 as a predictive biomarker in ovarian cancer
por: Masoodi, Mahak, et al.
Publicado: (2021)

Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010)

Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
por: Liu, Dan, et al.
Publicado: (2023)

Role of galectins in lung cancer
por: Chang, Wei-An, et al.
Publicado: (2017)

Galectin-9 in Gastroenterological Cancer
por: Morishita, Asahiro, et al.
Publicado: (2023)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1
por: Cousin, Jonathan M., et al.
Publicado: (2016)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015)

Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis
por: Hisrich, Brooke V., et al.
Publicado: (2020)

Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature
por: Brackmann, Melissa, et al.
Publicado: (2018)

The role of galectins in immunity and infection
por: Liu, Fu-Tong, et al.
Publicado: (2023)

Galectins and Gliomas
por: Le Mercier, Marie, et al.
Publicado: (2009)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients
por: Chen, Le, et al.
Publicado: (2015)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021)

Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017)

Galectins in epithelial functions
por: Viguier, Mireille, et al.
Publicado: (2014)

Galectin-1 in Obesity and Type 2 Diabetes
por: Fryk, Emanuel, et al.
Publicado: (2022)

Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
por: Lima, Tânia, et al.
Publicado: (2022)

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018)

The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
por: Bouberhan, Sara, et al.
Publicado: (2023)

Occupational Exposure to Asbestos and Ovarian Cancer: A Meta-analysis
por: Camargo, M. Constanza, et al.
Publicado: (2011)

The Role of Galectins in Cervical Cancer Biology and Progression
por: Wang, Lufang, et al.
Publicado: (2018)

Galectin-3 Is a Potential Mediator for Atherosclerosis
por: Gao, Ziyu, et al.
Publicado: (2020)

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
por: Godefa, Tesfay M., et al.
Publicado: (2022)

Galectokines: The Promiscuous Relationship between Galectins and Cytokines
por: Sanjurjo, Lucía, et al.
Publicado: (2022)

Galectins in Intra- and Extracellular Vesicles
por: Bänfer, Sebastian, et al.
Publicado: (2020)

Galectin-3 in Cardiovascular Diseases
por: Blanda, Valeria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmhpvee8bqhedqum1hsg6n507l